Navigation Links
Top Biopharma Company Adopts BioFortis' Translational Research Software for Centralized Management and Mining of Clinical Biomarker Data

COLUMBIA, Md., Sept. 10 /PRNewswire/ -- A top 5 bio-pharmaceutical company has licensed BioFortis' Labmatrix(TM) software for use enterprise-wide, across multiple therapeutic areas within its global Translational Medicine organization, BioFortis officials announced today. This large biopharmaceutical company decided to adopt the Labmatrix technology after an extensive review process that included a pilot by end users and the research informatics division. The company expects full implementation of Labmatrix to have a rapid and profound effect on the productivity of its Translational Medicine efforts.

"Labmatrix is the only data management and exploration application on the market that is built from the ground up to support translational medicine and biomarker discovery," said Jian Wang, BioFortis President and CEO. "There is a growing need in the biotechnology and pharmaceutical industry for robust informatics systems in the translational medicine space. This agreement demonstrates BioFortis' leadership position in fulfilling such needs," Dr. Wang concluded.

Labmatrix, an enterprise translational research information management software product, will be used to support Translational Medicine initiatives associated with research programs, clinical trials, and longitudinal clinical studies conducted with external collaborators.

About BioFortis

BioFortis is a privately-held company focused on providing biomedical research software and services to the life sciences sector, including government and academic research institutes and the biopharmaceutical industry. BioFortis' flagship product Labmatrix(TM) supports translational medicine initiatives with applications in clinical research, biobanking and biomarker discovery. Labmatrix enables transparent data management, integration, collaboration and compliance to privacy regulations.

SOURCE BioFortis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Therapure Biopharma Inc. opens for business with first client contracts
2. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
3. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
4. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
5. Ondine Biopharma Announces Second Quarter 2008 Financial Results
6. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
7. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
8. Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
9. ARCA biopharma Appoints James Carr as Vice President of Marketing
10. TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) Roaming Credentials
11. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
Post Your Comments:
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016   Ginkgo Bioworks , a ... engineering, was today awarded as one of the ... the world,s most innovative companies. Ginkgo Bioworks is ... the real world in the nutrition, health and ... directly with customers including Fortune 500 companies to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Researchers at ... most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the ... read it now. , Diagnostic biomarkers are signposts in the blood, lung fluid ...
Breaking Biology Technology:
(Date:6/2/2016)... YORK , June 2, 2016   The Weather ... is announcing Watson Ads, an industry-first capability in which consumers ... by being able to ask questions via voice or text ... Marketers have long sought ... the consumer, that can be personal, relevant and valuable; and ...
(Date:5/24/2016)... May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology ... LCD display is the latest premium product recently added to the range of products ... ... ... 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
Breaking Biology News(10 mins):